Structure-based discovery of antiviral inhibitors targeting the E dimer interface of Japanese encephalitis virus.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
23 07 2019
Historique:
received: 19 05 2019
accepted: 24 05 2019
pubmed: 4 6 2019
medline: 7 7 2020
entrez: 4 6 2019
Statut: ppublish

Résumé

Flaviviruses are emerging arthropod-borne viruses posing a great threat to human beings worldwide. The E dimer configuration of the flavivirus was prominent during viral assembly, maturation and entry. Neutralization antibodies targeting E dimer played the important role in controlling the flavivirus infection. Previously, the ideal drug target of small molecular inhibitors of JEV was viral proteases and polymerases. The crystal structure of JEV E protein showed a conserved pocket in it is important at membrane fusion step. Recently, a set of anti-virus drugs has been found by virtual screening. Here, we show that the fusion-loop pocket of JEV E protein was a conservative region and an ideal drug target. ChemDiv-3 from virtual screening as the lead compound was found to show a relatively modest inhibition effect for JEV in vitro and in vivo test and could interfere with the formation of JEV sE dimer. ChemDiv-3 interacts with the amino acid residues ASN 313, PRO 314, ALA 315, and VAL 323 in E protein via hydrogen bonds for occupation of the fusion-loop pocket. The key binding sites LYS 312, ALA 513 and THR 317 forming the fusion-loop pocket are the same and other auxiliary sites are similar among the flavivirus. Taken together, the fusion-loop pocket of the flavivirus could be one promising target for drug discovery.

Identifiants

pubmed: 31155294
pii: S0006-291X(19)31044-7
doi: 10.1016/j.bbrc.2019.05.148
pii:
doi:

Substances chimiques

Antiviral Agents 0
Viral Envelope Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

366-371

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Chuantao Ye (C)

Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Peiyu Bian (P)

Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Jing Zhang (J)

Beijing University of Chinese Medicine, Beijing, China.

Han Xiao (H)

Department of Microbiology, Fourth Military Medical University, Xi'an, China.

Li Zhang (L)

Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Wei Ye (W)

Department of Microbiology, Fourth Military Medical University, Xi'an, China.

Yangchao Dong (Y)

Department of Microbiology, Fourth Military Medical University, Xi'an, China.

Yun Zhou (Y)

Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Zhansheng Jia (Z)

Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, China. Electronic address: jiazsh@fmmu.edu.cn.

Yingfeng Lei (Y)

Department of Microbiology, Fourth Military Medical University, Xi'an, China. Electronic address: yflei@fmmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH